Resultados de procura - Norbert Arnold
- Mostrando 1 - 20 Resultados de 47
- Go to Next Page
-
1
Is the Ki-67 labelling index ready for clinical use? por W. Jonat, Norbert Arnold
Publicado 2011Carta -
2
-
3
Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation por Marion Kiechle, Anja Jacobsen, Ulrike Schwarz‐Boeger, J. Hedderich, Jacobus Pfisterer, Norbert Arnold
Publicado 2001Artigo -
4
Isolation of a New Natural Product and Cytotoxic and Antimicrobial Activities of Extracts from Fungi of Indonesian Marine Habitats por Kustiariyah Tarman, Ulrike Lindequist, Kristian Wende, Andrea Porzel, Norbert Arnold, Ludger A. Wessjohann
Publicado 2011Artigo -
5
Natural Products from Microalgae with Potential against Alzheimer’s Disease: Sulfolipids Are Potent Glutaminyl Cyclase Inhibitors por Stephanie Hielscher-Michael, Carola Griehl, Mirko Buchholz, Hans‐Ulrich Demuth, Norbert Arnold, Ludger A. Wessjohann
Publicado 2016Artigo -
6
LargeBRCA1 gene deletions are found in 3% of German high-risk breast cancer families por Carolin Hartmann, Anika L. John, R�diger Klaes, Wera Hofmann, Rainer Bielen, Rolf Koehler, Bart Janssen, Claus R. Bartram, Norbert Arnold, Johannes Zschocke
Publicado 2004Artigo -
7
Bispecific antibodies enhance tumor-infiltrating T cell cytotoxicity against autologous HER-2-expressing high-grade ovarian tumors por Hans‐Heinrich Oberg, Lisa Janitschke, Vjola Sulaj, Jörg Weimer, Daniel Gonnermann, Nina Hedemann, Norbert Arnold, Dieter Kabelitz, Matthias Peipp, Dirk Bauerschlag, Daniela Wesch
Publicado 2019Artigo -
8
-
9
Analysis of 30 Putative BRCA1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape In Silico Prediction por Barbara Wappenschmidt, Alexandra Becker, Jan Hauke, Weber Ute, Stefanie Engert, Juliane Köhler, Karin Kast, Norbert Arnold, Kerstin Rhiem, Eric Hahnen, Alfons Meindl, Rita K. Schmutzler
Publicado 2012Artigo -
10
Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer por Heide Hellebrand, Christian Sutter, Ellen Honisch, Eva Groß, Barbara Wappenschmidt, Christian Schem, Helmut Deißler, Nina Ditsch, Verena Gress, Marion Kiechle, Claus R. Bartram, Rita K. Schmutzler, Dieter Niederacher, Norbert Arnold, Alfons Meindl
Publicado 2011Artigo -
11
A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women por Sandrine Tchatchou, Anke Jung, Kari Hemminki, Christian Sutter, Barbara Wappenschmidt, Peter Bugert, Bernhard H. F. Weber, Dieter Niederacher, Norbert Arnold, Raymonda Varon-Mateeva, Nina Ditsch, Alfons Meindl, Rita K. Schmutzler, Claus R. Bartram, Barbara Burwinkel
Publicado 2008Artigo -
12
Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker por Ariane Sadr‐Nabavi, Juliane Ramser, Jens Volkmann, J. Naehrig, Frank Wiesmann, Beate Betz, Heide Hellebrand, Stefanie Engert, Susanne Seitz, Rene Kreutzfeld, Takako Sasaki, Norbert Arnold, Rita K. Schmutzler, Marion Kiechle, Dieter Niederacher, Nadia Harbeck, Edgar Dahl, Alfons Meindl
Publicado 2008Artigo -
13
Contralateral Breast Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers por Monika Graeser, Christoph Engel, Kerstin Rhiem, Dorothea Gadzicki, Ulrich Bick, Karin Kast, Ursula G. Froster, B. Schlehe, Astrid Bechtold, Norbert Arnold, Sabine Preisler-Adams, Carolin Nestle-Kraemling, Mohammad Zaino, Markus Loeffler, Marion Kiechle, Alfons Meindl, Dominic Varga, Rita K. Schmutzler
Publicado 2009Artigo -
14
Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer por Antonia Wenners, Keyur Mehta, Sibylle Loibl, Hye‐Rim Park, Berit Mueller, Norbert Arnold, Sigrid Hamann, Jörg Weimer, Beyhan Ataseven, Silvia Darb‐Esfahani, Christian Schem, Christoph Mundhenke, F Khandan, Christoph Thomssen, W. Jonat, Hans-Juergen Holzhausen, Gunther von Minckwitz, Carsten Denkert, M. Bauer
Publicado 2012Artigo -
15
Limited relevance of the <i>CHEK2</i> gene in hereditary breast cancer por Michael R. Dufault, Beate Betz, Barbara Wappenschmidt, Wera Hofmann, Katrin Bandick, Astrid Golla, Andrea Pietschmann, C. Nestle-Krämling, Kerstin Rhiem, Christine Hüttner, Celia von Lindern, Peter Dall, Marion Kiechle, Michael Untch, W. Jonat, Alfons Meindl, Siegfried Scherneck, Dieter Niederacher, Rita K. Schmutzler, Norbert Arnold
Publicado 2004Artigo -
16
Evaluation of SNPs in<i>miR-146a</i>,<i>miR196a2</i>and<i>miR-499</i>as low-penetrance alleles in German and Italian familial breast cancer cases por Irene Catucci, Rongxi Yang, Paolo Verderio, Sara Pizzamiglio, Ludwig Heesen, Kari Hemminki, Christian Sutter, Barbara Wappenschmidt, Michèlle Dick, Norbert Arnold, Peter Bugert, Dieter Niederacher, Alfons Meindl, Rita K. Schmutzler, Claus C. Bartram, Filomena Ficarazzi, Laura Tizzoni, Daniela Zaffaroni, Siranoush Manoukian, Monica Barile, Marco A. Pierotti, Paolo Radice, Barbara Burwinkel, Paolo Peterlongo
Publicado 2009Artigo -
17
A critical spotlight on the paradigms of FFPE-DNA sequencing por Tim Alexander Steiert, Genı́s Parra, Marta Gut, Norbert Arnold, Jean-Rémi Trotta, Raúl Tonda, Alice Moussy, Zuzana Gerber, Peter M. Abuja, Kurt Zatloukal, Christoph Röcken, Trine Folseraas, Marit M. Grimsrud, Arndt Vogel, Benjamin Goeppert, Stephanie Roessler, Sebastian Hinz, Clemens Schafmayer, Philip Rosenstiel, Jean‐François Deleuze, Marta Gut, André Franke, Michael Förster
Publicado 2023Revisão -
18
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer por Clara Andradas, Sandra Blasco-Benito, Sonia Castillo‐Lluva, Patrícia Dillenburg-Pilla, Rebeca Dı́ez-Alarcia, Alba Juanes-García, Elena García-Taboada, Rodrigo Hernando-Llorente, Joaquím Soriano, Sigrid Hamann, Antonia Wenners, İbrahim Alkatout, Wolfram Klapper, Christoph Röcken, M. Bauer, Norbert Arnold, Miguel Quintanilla, Diego Megı́as, Miguel Vicente‐Manzanares, Leyre Urigüen, J. Silvio Gutkind, Manuel Guzmán, Eduardo Pérez-Gómez, Cristina Sánchez
Publicado 2016Artigo -
19
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history por Christoph Engel, Kerstin Rhiem, Eric Hahnen, Sibylle Loibl, Karsten E. Weber, Sabine Seiler, Silke Zachariae, Jan Hauke, Barbara Wappenschmidt, Anke Waha, Britta Blümcke, Marion Kiechle, Alfons Meindl, Dieter Niederacher, Claus R. Bartram, Dorothee Speiser, Brigitte Schlegelberger, Norbert Arnold, Peter Wieacker, Elena Leinert, Andrea Gehrig, Susanne Briest, Karin Kast, Olaf Rieß, Günter Emons, Bernhard H. F. Weber, Jutta Engel, Rita K. Schmutzler
Publicado 2018Artigo -
20
Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer por Nana Weber‐Lassalle, Julika Borde, Konstantin Weber‐Lassalle, Judit Horváth, Dieter Niederacher, Norbert Arnold, Silke Kaulfuß, Corinna Ernst, Victoria Paul, Ellen Honisch, Kristina Klaschik, Alexander E. Volk, Christian Kubisch, Steffen Rapp, Nadine Lichey, Janine Altmüller, Louisa Lepkes, Esther Pohl‐Rescigno, Hölger Thiele, Peter Nürnberg, Mirjam Larsen, Lisa Richters, Kerstin Rhiem, Barbara Wappenschmidt, Christoph Engel, Alfons Meindl, Rita K. Schmutzler, Eric Hahnen, Jan Hauke
Publicado 2019Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Genetics
Cancer
Medicine
Gene
Breast cancer
Internal medicine
Oncology
Mutation
Germline mutation
Genotype
Ovarian cancer
Single-nucleotide polymorphism
Allele
Cancer research
Gynecology
Population
BRCA2 Protein
Bioinformatics
Computational biology
Environmental health
Missense mutation
Germline
Odds ratio
Pathology
Surgical oncology
BRCA mutation
Family history
Biochemistry
Botany